Switch View
© PR Newswire
26.08.2025
ISIN: CNE100001M79
Shanghai Fosun Pharma (Group) Co., Ltd
2196
LISTED
HKSE
Fosun Pharma Announces 2025 Interim Results
News Preview
Enhancing Innovation Efficiency and Steadily Expanding Globally
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company, announced its operating performance for the first half of 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
AcariaHealth Sparks Innovation at 2025 Healthcare Advocate Summit with Hackathon and Expert Panels
News Preview
LAS VEGAS, Aug. 26, 2025 /PRNewswire/ -- AcariaHealth, a leader in specialty pharmacy solutions and a Centene Corporation company (NYSE: CNC), is taking center stage at the 2025 Healthcare Advocate Summit (Sept. 2–5) in Las Vegas with a first-of-its-kind "Reimagine Access" Hackathon and two can't-miss expert sessions....
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US42225T1079
Health Catalyst Inc
HCAT
LISTED
NASDAQ
Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange
News Preview
Hospitals and Health Systems Can Now Benefit from a Validated Consumer Science Model and Proprietary Business Intelligence
SALT LAKE CITY, Aug. 26, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Upfront...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
26.08.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Dexcom Announces Upcoming Conference Presentations
News Preview
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:
The 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 2:15 pm (EDT)
The Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 2:00 pm (EDT)
Links to...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
26.08.2025
ISIN: US92337F1075
Veracyte Inc
VCYT
LISTED
NASDAQ
Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test
News Preview
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the NIGHTINGALE trial, which aims to evaluate the clinical utility of its Percepta Nasal Swab test. The milestone marks an important step in Veracyte’s goal of making the novel molecular test widely available and helping clin...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Updates Bitcoin Balance Sheet Strategy
News Preview
Purchases of iShares Bitcoin ETF (IBIT) and Progress Toward Arch Public IntegrationToronto, Ontario--(Newsfile Corp. - August 26, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US7665596034
Rigel Pharmaceuticals, Inc.
RIGL
LISTED
NASDAQ
Rigel to Participate in Upcoming September Investor Conferences
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and chief executive officer, and Dean Schorno, the company's chief financial officer, will partici...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
News Preview
Complete submission of the Biologics License Application (BLA) remains on track for 2H25 with the goal of file acceptance by U.S. Food and Drug Administration (FDA) by end of 2025
PLYMOUTH MEETING, Pa., Aug. 26, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US4131971040
Harmony Biosciences Holdings Inc
HRMY
LISTED
NASDAQ
Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
News Preview
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will present data from its rare epilepsy pipeline at the 36th International Epilepsy Congress (IEC) being held August 30 – September 3, 2025, at the Lisbon Congress Centre in Lisbon, Portugal.
Poster presentations will highlight information from the company’s investigatio...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US70387R4039
PAVmed, Inc.
PAVM
LISTED
NASDAQ
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology
News Preview
Newly-formed PAVmed subsidiary to license endoscopic imaging technology designed to identify and facilitate ablative treatment of esophageal dysplasia
Lucid Diagnostics to collaborate with PAVmed as a strategic and equity partner on the technology
NEW YORK, Aug. 26, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a di...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve-Branded Dispensary to Open in Cincinnati, Ohio
News Preview
New Hamilton County dispensary will host grand opening celebration Friday, August 29th
TALLAHASSEE, Fla., Aug. 26, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new Trulieve-branded dispensary in Cincinnati...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve-Branded Dispensary to Open in Cincinnati, Ohio
News Preview
New Hamilton County dispensary will host grand opening celebration Friday, August 29th
TALLAHASSEE, Fla., Aug. 26, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new Trulieve-branded dispensary in Cin...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
26.08.2025
ISIN: DE0005313704
Carl Zeiss Meditec AG
AFX
LISTED
XETR
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA
News Preview
At EURETINA 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care:
IMPROVE PATHOLOGY DETECTION: Now CE mark approved, CIRRUS® PathFinderTM AI decision support tool streamlines OCT data review; ICGA for CLARUS® 700 offers FA + ICG simultaneous capture...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US28414H1032
Elanco Animal Health Inc
ELAN
LISTED
NYSE
Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
GREENFIELD, Ind., Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 23rd Annual Global Healthcare Conference, September 8-9, 2025. Jeff Simmons, President and CEO, and Bob VanHimbergen, Executive Vice President and CFO, will participate in a fireside chat on Tuesday, September 9 at 8:30 a....
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Announces Non-Brokered Private Placement & Extends Warrants
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - August 26, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of br...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board
News Preview
Extinguishment simplifies capital structure, strengthens foundation for growth, and eliminates all term loan obligations, without equity conversionWhite Bear Lake, Minnesota--(Newsfile Corp. - August 26, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully impl...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems, Inc. Announces Expiration and Final Tender Results of Previously Announced Tender Offer for 5.625% Senior Secured Notes Due 2027
News Preview
Community Health Systems, Inc. (the “Company”) (NYSE: CYH) announced today the expiration and final tender results of the previously announced cash tender offer (the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase for cash any and all of the Issuer’s outstanding 5.625% Senior Secured N...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US53566P1093
Lineage Cell Therapeutics Inc.
LCTX
LISTED
TLV
Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss
News Preview
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell therapies for serious neurological and ophthalmic conditions, today announced that it has entered into a research collaboration with and through an investment from William Demant Invest A/S (W...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Foundation Announces 2025 Scholarship Awards
News Preview
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250826215584/en/Humana employee Cyrena Ferrell with her...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Alcon to Present at 2025 Baird Global Healthcare Conference
News Preview
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 Baird Global Healthcare Conference on Tuesday, September 9, 2025, at 9:05 a.m. ET.
A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye car...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US3723032062
Genmab A/S
GMAB
LISTED
NASDAQ
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)
News Preview
Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to rinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-directed, TOPO1-inhibitor antibody-drug conjugate (ADC), for the treatment of adult patients with recurrent or progressive en...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) has joined the EASYGEN (Easy Workflow Integration for Gene Therapy) Consortium, a European Union (EU)-backed effort to produce CAR-T cell therapies faster, make them more affordable, and increase patient access throughout Europe. The Consortium aims to develop a fully automated, hospital-b...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 22 August 2025 was 356.21p (cum income). ...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab to Participate in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
Media ReleaseCOPENHAGEN, Denmark; August 26, 2025Genmab A/S (Nasdaq: GMAB) announced today that its Chief Executive Officer Jan Van de Winkel and Chief Financial Officer Anthony Pagano will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York City, NY at 7:45 AM EDT (1:45 PM CEST) on September 9,...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ISIN: CA64082X2032
Nervgen Pharma Corp.
NGEN
LISTED
TSX
NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders
News Preview
Announced unprecedented Phase 1b/2a topline results in chronic spinal cord injury NVG-291 is the first pharmacologic candidate to demonstrate statistically significant improvement in corticospinal connectivity with clinically meaningful functional gainsOngoing comprehensive analysis of NVG-291's efficacy profile will support upcoming regulatory dis...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Superior HealthPlan Helps 45,000 Texans Gear Up for School at 88 Community Events
News Preview
The events gave students access to health checkups, school supplies, and other resources ahead of the 2025-26 school year.
AUSTIN, Texas, Aug. 26, 2025 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene (NYSE: CNC), participated in 88 back-to-school events in July and August, pr...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced a new publication in the Journal Thyroid. The First-in-Human Clinical feasibility study demonstrates the effectiveness of ablation of benign thyroid nodules using nsPFA ener...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US45781M1018
Innoviva Inc
INVA
LISTED
NASDAQ
Innoviva to Participate in Upcoming Investor Conferences
News Preview
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
News Preview
In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines
Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 22.9 lbs (10.5%) on the highest dose, wi...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US20678X1063
Conduit Pharmaceuticals Inc.
CDT
LISTED
NASDAQ
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy
News Preview
CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US1850631045
Clearside Biomedical Inc
CLSD
LISTED
NASDAQ
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress
News Preview
- Presentations Highlight the Versatility of Clearside’s SCS Microinjector® Platform for the Treatment of Multiple Retinal Diseases -...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, with a fireside chat at 1:50 p.m. EDT.
The live webcast of this event can be accessed from the investors section of the Company’s website...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US3596161097
Fulcrum Therapeutics Inc
FULC
LISTED
NASDAQ
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
News Preview
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that company management will attend and present at the following i...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US20454B1044
Compass Therapeutics Inc.
CMPX
LISTED
NASDAQ
Compass Therapeutics to Participate in Upcoming September Investor Events
News Preview
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of Se...
Themefolio
Profiler
Peergroup
© Newsfile
26.08.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces 13th Consecutive Record Quarter, and Increased Positive Net Income from Operations
News Preview
Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce its unaudited financial results and corporate update for the fiscal quarter ended June 30th, 2025."In Q2 2025, Ha...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US4884452065
Zevra Therapeutics Inc
ZVRA
LISTED
NASDAQ
Zevra Therapeutics to Participate at Upcoming Investor Conferences in September
News Preview
CELEBRATION, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate in the following September events:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US23126K1060
Curanex Pharmaceuticals, Inc.
CURX
LISTED
NASDAQ
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
News Preview
Jericho, New York, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc. (Nasdaq: CURX) ("Curanex" or the "Company"), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the pricing of its initial public offering (the “Offering”) of 3,750,000 shares...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology
News Preview
NEW HOPE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the publication of data in the Journal of the American College of Cardiology: Clinica...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US0327973006
Anavex Life Sciences Corp
AVXL
LISTED
NASDAQ
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine
News Preview
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, an...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune to Participate in Upcoming Investor Conferences
News Preview
GAITHERSBURG, Md., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing peptide-based therapeutics for liver and cardiometabolic diseases, today announced that management will participate and be available for one-on-one meetings at the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: CA10778Y1043
BriaCell Therapeutics Corp.
BCT
LISTED
TSX
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
News Preview
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the publication of the mechanism of action of its next...
Themefolio
Profiler
Peergroup
© EQS Newswire
26.08.2025
ISIN: FR0004056851
Valneva SE
VLA
LISTED
EURONEXT
First Berlin Equity Research GmbH: Valneva SE | Rating: Buy
News Preview
Original-Research: Valneva SE - from First Berlin Equity Research GmbH
26.08.2025 / 11:25 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain......
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US2210061097
CorVel Corp
CRVL
LISTED
NASDAQ
The Save Mart Companies Honored for Transforming Workers’ Comp Program in Collaboration with CorVel
News Preview
FORT WORTH, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, congratulates its partner, The Save Mart Companies, one of the West Coast's largest regional, full-service grocery chains, for being named one of three recipients of the 2025 Workers’ Compensation Risk Manageme...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US98937L1052
Zenas BioPharma, Inc.
ZBIO
LISTED
NASDAQ
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
News Preview
WALTHAM, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for autoimmune diseases, today announced management’s presentations at the following i...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
News Preview
WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in three upcomin...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US7867001049
Sagimet Biosciences Inc
SGMT
LISTED
NASDAQ
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
News Preview
SAN MATEO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US87164F1057
Syndax Pharmaceuticals Inc
SNDX
LISTED
NASDAQ
Syndax Announces Participation in September Investor Conferences
News Preview
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US92915B1061
Voyager Therapeutics Inc
VYGR
LISTED
NASDAQ
Voyager to Present at Upcoming Investor Conferences
News Preview
LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Announces Participation at Upcoming Investor Conferences
News Preview
WATERTOWN, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US87583X1090
Tango Therapeutics Inc
TNGX
LISTED
NASDAQ
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
News Preview
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Wednesday, September 3 at 2:45-3:15 PM ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
News Preview
Cemdisiran monotherapy, dosed subcutaneously every three months, met the primary and key secondary endpoints, showing a 2.3-point placebo-adjusted improvement in Myasthenia Gravis Activities of Daily Living (MG-ADL) total score...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US57055L1070
Marker Therapeutics, Inc.
MRKR
LISTED
NASDAQ
Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma
News Preview
Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 66% of Non-Hodgkin Lymphoma (NHL) patients achieving objective response rates, with 50% demonstrating complete response (CR)...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US30049G1040
Evoke Pharma Inc
EVOK
LISTED
NASDAQ
Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship
News Preview
Separately Secures Access to OneGI Through Brentwood Pharmacy Agreement...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 4:50 p.m. ET on Monday, September 8, 2025 (6:50 a.m. AEST, Sep 9) and at the H.C. Wainwright 27th Annual Global Investment Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US8793691069
Teleflex Inc
TFX
LISTED
NYSE
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. (ET)....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.08.2025
ISIN: US82024L1035
Shattuck Labs Inc
STTK
LISTED
NASDAQ
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
News Preview
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease —...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Michael Jordan's Game-Worn Sneakers Headline 'The Grail Collection' at Infinite Auctions (OTC Pink:MDCE)
News Preview
Five Iconic Michael Jordan Game-Worn Sneakers Headline Elite Sports Memorabilia Auction MESA, ARIZONA / ACCESS Newswire / August 26, 2025 / Infinite Auctions, a subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), is proud to announce the "The Grail Collection," available exclusively at www.infiniteauctions.com. This highly antic...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Yeytuo® (lenacapavir)—the company’s twice-yearly injectable HIV-1 capsid inhibitor—for use as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents with increased HIV-1 acq...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.08.2025
ISIN: US83558L2043
Sonoma Pharmaceuticals, Inc.
SNOA
LISTED
NASDAQ
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
News Preview
BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal heal...
Themefolio
Profiler
Peergroup
© PR Newswire
26.08.2025
ISIN: US0028241000
Abbott Laboratories
ABT
LISTED
NYSE
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
News Preview
Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for millions of ThaisThis approval builds on Abbott's biosimilar portfolio in Asia Pacific, following recent launches in Malaysia and IndiaBANGKOK, Aug. 26, 2025 /PRNewswire/ -- Abbott (NYSE: ABT),...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
